WuXi PharmaTech Announces Fourth Quarter and Full Year 20...(g solutions that save its customersboth ...)

Use of Non-GAAP Financial Measures

We have provided the fourth quarter and full year of 2006 and 2007 net income and earnings per ADS on a non-GAAP basis, which excludes share-based compensation expenses. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our financial performance and liquidity and when planning and forecasting future periods. These non-GAAP operating measures are useful for understanding and assessing underlying business performance and operating trends. We expect to provide net income and earnings per ADS on a non-GAAP basis using a consistent method on a quarterly basis going forward.

You should not view non-GAAP results on a stand-alone basis or as a substitute for results under GAAP, or as being comparable to results reported or forecasted by other companies, and should refer to the reconciliation of non-GAAP measures to GAAP measures for the indicated periods attached hereto.

Cautionary Note Regarding Forward-Looking Statements

Statements in this release contains "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the Private Securities Litigation Reform Act of 1995, including, among others, the acceptance of and revenues generating from new toxicology and formulation services, the timing of opening facilities in Jinshan and Suzhou, and our integration of AppTec Laboratory Services, including creating a unified global operation, retaining key AppTec management, organizing our sales and marketing teams, reorganizing our service lines, and realizing benefits from the acquisition generally. These forward-looking statements are n
'/>"/>